Thrombosis following phlebography with ionic and non-ionic contrast media

Area of Science:

• Radiology
• Vascular Imaging
• Contrast Media Research

Background:

• Phlebography is a key diagnostic tool for lower limb venous conditions.
• Iodinated contrast media are commonly used, but potential side effects require evaluation.
• Assessing the thrombogenic potential of different contrast agents is crucial for patient safety.

Purpose of the Study:

• To compare the incidence of post-phlebographic thrombosis between an ionic and a non-ionic contrast medium.
• To evaluate the safety and side-effect profiles of meglumine-metrizoate versus metrizamide in lower limb phlebography.

Main Methods:

• A comparative study evaluating lower limb phlebography procedures.
• Utilized meglumine-metrizoate (ionic) and metrizamide (non-ionic) contrast media.
• Assessed post-phlebographic thrombosis using 125I-fibrinogen uptake.

Main Results:

• Six out of the group examined with meglumine-metrizoate showed increased 125I-fibrinogen uptake, indicating thrombosis.
• None of the patients examined with metrizamide exhibited increased 125I-fibrinogen uptake.
• The observed difference in thrombosis incidence was statistically significant (p < 0.002).

Conclusions:

• Non-ionic contrast media, specifically metrizamide, demonstrate a significantly lower risk of inducing post-phlebographic thrombosis compared to ionic agents like meglumine-metrizoate.
• These findings suggest that non-ionic contrast agents are preferable for lower limb phlebography to enhance patient safety and minimize complications.